BioInvent International
Emma Tordebrand worked as a Quality Control Engineer at BioInvent International AB starting in June 2022. Prior to that, they completed an internship as a Praktikant at Region Skåne from March 2022 to May 2022. In 2021, Emma also worked as an Examensprojekt and Praktikant at ImaGene-iT from November 2021 to January 2022 and from January 2022 to March 2022, respectively.
Emma Tordebrand attended Malmö University from 2015 to 2022, where they obtained a Kandidatexamen in Biomedicinsk analytiker. Prior to that, they studied at Lernia College from 2011 to 2013, earning a YH-examen in Apotekstekniker med receptbehörighet. In 2009, they briefly attended Malmö University, studying Biomedicinsk teknik.
This person is not in the org chart
This person is not in any offices
BioInvent International
BioInvent International AB (Nasdaq Stockholm: BINV) is a clinical-stage biotech company that discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently three drug candidates in four ongoing clinical programs in Phase l/ll trials for the treatment of hematological cancer and solid tumors, respectively.